ARE WE

Twenty-nine qualified “Research Centers” across twelve states, with expertise in managing all four phases of the clinical trial process (Phases I, II, III, and IV) and, in some cases, preclinical studies. These centers support the entire healthcare ecosystem and the pharmaceutical industry, including sponsors, physicians, institutions and researchers, schools and universities, patient advocacy groups (PAGs), associations, regulatory authorities, and government agencies (CEP, CONEP, ANVISA, EMA, and FDA). Learn more about our expansion plan for research centers:

Number of Research Sites by state is represented by the numeral within the state or next to the state name.